Can you discuss the recommendations for biologic therapy in RA issued by the ACR guidelines and compare these to the EULAR guidelines for RA? Where do IL-6 inhibitors fall into the treatment pathways?

Can you discuss the recommendations for biologic therapy in RA issued by the ACR guidelines and compare these to the EULAR guidelines for RA? Where do IL-6 inhibitors fall into the treatment pathways?

Can you discuss the critical recommendations for biologic therapy in RA issued by the ACR guidelines and compare these to the recently reported EULAR guidelines for RA? How are they similar? How are they different? Where do IL-6 inhibitors fall into the treatment pathways?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Roy Fleischmann, MD

Roy Fleischmann, MD

Clinical Professor of Medicine University of Texas Southwestern Medical Center at Dallas Co-Director, Division of Rheumatology Texas Health Presbyterian Medical Center and Co-Medical Director Metroplex Clinical Research Center